Nearly Unknown Biotech Stock Could Parabola If Pipeline Hits
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
A zero-spend month concentrates spending to essentials, directing more money toward debt. Plan, track, and celebrate smaller, steady wins.
16,055 articlesSmall, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...
As market conditions shift in 2026, five very safe high-yield dividend stocks stand out for lifelong ownership, backe...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
When insider-like conviction meets market risk, funds can double down on a stock. This analysis explains why Black Cy...
President Donald Trump escalated tensions with Spain by threatening a broad trade squeeze after Madrid refused to len...
A major trading move shows Clearline Capital expanding its Core Scientific holding just as Bitcoin mining evolves int...
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...